Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Aug 2024, 16:16:52 UTC
Prior SEC filing
12 Aug 2024
Next SEC filing
13 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer
Filing notes and source

Key filing fact

Versant Venture Capital VI, L.P. filed Form 4 for Black Diamond Therapeutics, Inc. (BDTX) on 30 Aug 2024.

Key facts

  • This page summarizes Versant Venture Capital VI, L.P.'s Form 4 filing for Black Diamond Therapeutics, Inc. (BDTX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Aug 2024, 16:16.

Change

  • Previous filing in this sequence was filed on 12 Aug 2024.
  • Current net transaction value: -$1,400,556.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDTX transaction

Common Stock

Sale

Transaction value
-$1,400,556
Shares
-221,600
Change %
-5.6%
Price
$6.32
Shares after
3,726,341
Date
28 Aug 2024
Ownership
Direct
Footnotes
F1, F2
BDTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,277,541
Date
28 Aug 2024
Ownership
See Footnote
Footnotes
F3
BDTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
380,942
Date
28 Aug 2024
Ownership
See Footnote
Footnotes
F4
BDTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
822,140
Date
28 Aug 2024
Ownership
See Footnote
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.32 to $6.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Footnote F2

These shares are held of record by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.

Footnote F3

These shares are held of record by Versant Voyageurs I, L.P. ("Versant Voyageurs I"). Versant Voyageurs I GP Company ("Versant Voyageurs I GP") is the general partner of Versant Voyageurs I and may be deemed to share voting, investment and dispositive power over the shares held by Versant Voyageurs I. Versant Voyageurs I GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interests therein.

Footnote F4

These shares are held of record by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel"). Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP LP") is the general partner of Versant I Parallel and may be deemed to share voting, investment and dispositive power over the shares held by Versant I Parallel and disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein.

Footnote F5

These shares are held of record by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP LP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP LP and each may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP-GP and Versant Vantage I GP LP disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .